Wagner Paul A. — SEC insider filings

SEC reporting owner CIK 1612842. 31 insider filings on record with FilingPulse; latest filed 2026-08-27.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2021-04-13 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Forte Biosciences, Inc. (FBRX)SEE REMARKS, Director3113 legs · 218,865 sh · $179,7121 leg · 1,000,000 sh · $4,347,10063

Insider filings — Wagner Paul A.

FiledFormIssuerReported transactionsSource
2026-08-274Forte Biosciences, Inc. (FBRX)Code (U): 85,482 · Disposition to issuer (D): 16,866 (derivative) · Disposition to issuer (D): 5,400 (derivative) · Disposition to issuer (D): 11,999 (derivative) · Disposition to issuer (D): 44,000 (derivative) · Disposition to issuer (D): 920,000 (derivative) · +5 moreEDGAR
2026-07-064Forte Biosciences, Inc. (FBRX)Option exercise (M): 1,250 · Tax withholding (F): 98 @ $21.32 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2026-06-174Forte Biosciences, Inc. (FBRX)Grant/award (A): 500,000 (derivative) @ $0EDGAR
2026-04-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 1,250 · Tax withholding (F): 98 @ $24.86 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2026-01-134Forte Biosciences, Inc. (FBRX)Grant/award (A): 270,000 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0EDGAR
2026-01-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 1,250 @ $0 · Tax withholding (F): 164 @ $27.27 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2025-10-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $14.52 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2025-07-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $12.44 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2025-04-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 1,250 @ $0 · Tax withholding (F): 18 @ $7.43 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2025-03-214Forte Biosciences, Inc. (FBRX)Grant/award (A): 920,000 (derivative) @ $0EDGAR
2025-01-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 1,250 @ $0 · Tax withholding (F): 164 @ $22.71 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2024-10-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $5.16 · Option exercise (M): 1,250 (derivative) @ $0EDGAR
2024-07-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 31,250 @ $0 · Tax withholding (F): 2,453 @ $0.55 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2024-04-024Forte Biosciences, Inc. (FBRX)Option exercise (M): 31,250 @ $0 · Tax withholding (F): 2,453 @ $0.71 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2024-03-254Forte Biosciences, Inc. (FBRX)Grant/award (A): 1,100,000 (derivative) @ $0EDGAR
2024-01-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 31,250 @ $0 · Tax withholding (F): 4,109 @ $0.82 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2023-12-204Forte Biosciences, Inc. (FBRX)Purchase (P): 10,000 @ $0.75EDGAR
2023-12-154Forte Biosciences, Inc. (FBRX)Purchase (P): 10,520 @ $0.70 · Purchase (P): 10,000 @ $0.72EDGAR
2023-12-124Forte Biosciences, Inc. (FBRX)Purchase (P): 25,000 @ $0.65 · Purchase (P): 4,776 @ $0.65EDGAR
2023-12-084Forte Biosciences, Inc. (FBRX)Purchase (P): 36,203 @ $0.58 · Purchase (P): 15,000 @ $0.62EDGAR
2023-11-224Forte Biosciences, Inc. (FBRX)Purchase (P): 5,300 @ $0.44 · Purchase (P): 1,566 @ $0.43 · Purchase (P): 100 @ $0.43 · Purchase (P): 400 @ $0.43EDGAR
2023-10-034Forte Biosciences, Inc. (FBRX)Option exercise (M): 31,250 @ $0 · Tax withholding (F): 2,453 @ $0.66 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2023-08-024Forte Biosciences, Inc. (FBRX)Grant/award (A): 247,524 @ $1.01EDGAR
2023-07-054Forte Biosciences, Inc. (FBRX)Option exercise (M): 31,250 @ $0 · Tax withholding (F): 2,453 @ $1.04 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2023-04-044Forte Biosciences, Inc. (FBRX)Option exercise (M): 31,250 @ $0 · Tax withholding (F): 11,046 @ $1.01 · Option exercise (M): 31,250 (derivative) @ $0EDGAR
2023-03-234Forte Biosciences, Inc. (FBRX)Grant/award (A): 500,000 (derivative) @ $0EDGAR
2022-12-194Forte Biosciences, Inc. (FBRX)Purchase (P): 55,976 @ $1.03 · Purchase (P): 44,024 @ $1.07EDGAR
2022-05-164Forte Biosciences, Inc. (FBRX)Disposition to issuer (D): 40,000 (derivative) @ $0EDGAR
2022-01-184Forte Biosciences, Inc. (FBRX)Grant/award (A): 300,000 (derivative) @ $0EDGAR
2021-09-084Forte Biosciences, Inc. (FBRX)Sale (S): 1,000,000 @ $4.35EDGAR
2021-04-134Forte Biosciences, Inc. (FBRX)Grant/award (A): 175,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1612842 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs